Professor, Internal Medicine, University of Texas Southwestern Medical Center, Southwestern Medical School
Internal Medicine
Dr. Khashayar Sakhaee, MD
|
|
Give Review
Doctor Khashayar Sakhaee, MD practices Internal Medicine. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Dr. Khashayar Sakhaee is also published. He has 101 publications published. The lastest publication: "Reduction in intestinal calcium absorption by hydrochlorothiazide in postmenopausal osteoporosis.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- The effects of bariatric surgery on bone and nephrolithiasis.
- Relationship Between Serum Uric Acid and Bone Mineral Density in the General Population and in Rats With Experimental Hyperuricemia.
- Pathophysiological and physicochemical basis of ammonium urate stone formation in dolphins.
- Epidemiology and clinical pathophysiology of uric acid Kidney stones.
- Animal protein and the risk of Kidney stones: a comparative metabolic study of animal protein sources.
- Body Fat Content and Distribution and Urinary Risk Factors for Nephrolithiasis.
- Effects of Sex and Postmenopausal Estrogen Use on Serum Phosphorus Levels: A Cross-sectional Study of the National Health and Nutrition Examination Survey (NHANES) 200...
- Renal ammonium excretion after an Acute acid load: Blunted response in uric acid stone formers but not in patients with type 2 diabetes.
- Hyperinsulinemia and Urinary Calcium Excretion in Calcium Stone Formers with Idiopathic Hypercalciuria.
- Prevalence and spot urine risk factors for Renal stones in children taking topiramate.
- Risk factors for diminished bone Mineral density among male hemodialysis patients-a cross-sectional study.
- The effects of smoking on bone Metabolism.
- Subclinical Celiac Disease and Crystal-Induced Kidney Disease Following Kidney Transplant.
- Kidney Stones 2012: Pathogenesis, Diagnosis, and Management.
- Superior Calcium bioavailability of effervescent potassium Calcium citrate over tablet formulation of Calcium citrate after Roux-en-Y gastric bypass.
- Effect of low-carbohydrate high-protein diets on acid-base balance, stone-forming propensity, and Calcium metabolism.
- Pathophysiologic basis for normouricosuric uric acid nephrolithiasis.
- Etiological role of estrogen status in Renal stone formation.
- Effect of subcutaneous leptin replacement therapy on bone Metabolism in patients with generalized lipodystrophy.
- Biochemical distinction between hyperuricosuric Calcium urolithiasis and gouty diathesis.
- Pathophysiology of uric acid nephrolithiasis.
- Biochemical profile of stone-forming patients with Diabetes mellitus.
- The metabolic syndrome and uric acid nephrolithiasis: novel features of Renal manifestation of insulin resistance.
- Association of urinary pH With body weight in nephrolithiasis.
- Novel insights into the pathogenesis of uric acid nephrolithiasis.
- Recurrent Calcium nephrolithiasis associated with primary aldosteronism.
- Stone forming risk of Calcium citrate supplementation in healthy postmenopausal women.
- A case of chromosome 22q11 deletion syndrome diagnosed in a 32-year-old man With hypoparathyroidism.
- Effects of potassium alkali and Calcium supplementation on bone turnover in postmenopausal women.
- Physicochemical metabolic characteristics for Calcium oxalate stone formation in patients with gouty diathesis.
- Dietary Calcium, obesity and hypertension--the end of the road?
- Nephrolithiasis in children.
- Effect of dietary modification on urinary stone risk factors.
- Post-Renal transplantation hypophosphatemia: a review and novel insights.
- Bisphosphonate-induced hypocalcemia: report of 3 cases and review of literature.
- Urine composition in type 2 Diabetes: predisposition to uric acid nephrolithiasis.
- Post-Renal transplantation hypophosphatemia.
- Hypocitraturia and hyperoxaluria after Roux-en-Y gastric bypass surgery.
- Metabolic basis for low urine pH in type 2 Diabetes.
- High prevalence of Gouty arthritis among the Hmong population in Minnesota.
- Lovastatin raises serum osteoprotegerin level in people With type 2 diabetic nephropathy.
- Pharmacotherapy of urolithiasis: evidence from clinical trials.
- Postmenopausal hormone use and the risk of nephrolithiasis: results from the Women's Health Initiative hormone therapy trials.
- Evidence for metabolic origin of absorptive hypercalciuria Type II.
- Nephrolithiasis-associated bone Disease: pathogenesis and treatment options.
- Nephrolithiasis in topiramate users.
- Detection of absorptive hypercalciuria type I without the oral Calcium load test.
- Fasting versus 24-h urine pH in the evaluation of nephrolithiasis.
- Biochemical control of bone loss and stone-forming propensity by potassium-Calcium citrate after bariatric surgery.
- Comparison of Insulin Action on Glucose versus Potassium Uptake in Humans.
- Defining hypercalciuria in nephrolithiasis.
- Hypercalciuria Associated With High Dietary Protein Intake Is Not Due to Acid Load.
- Biochemical and stone-risk profiles With topiramate treatment.
- Biochemical characterization of primary hyperparathyroidism with and without Kidney stones.
- Circadian variation in urine pH and uric acid nephrolithiasis risk.
- Uric acid nephrolithiasis.
- Low urine pH: a novel feature of the metabolic syndrome.
- Increased propensity for calcium phosphate Kidney stones with topiramate use.
- CLINICAL Review #: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implications.
- Metabolic syndrome and uric acid nephrolithiasis.
- Nephrolithiasis as a systemic disorder.
- Renal phosphate wasting due to tumor-induced osteomalacia: a frequently delayed diagnosis.
- New methods of assessing crystal growth and saturation of brushite in whole urine: effect of pH, Calcium and citrate.
- Recent advances in the pathophysiology of nephrolithiasis.
- Pharmacology of stone Disease.
- Effect of a high-fiber diet compared with a moderate-fiber diet on Calcium and other mineral balances in subjects with type 2 diabetes.
- Comparison of the absorption of Calcium carbonate and Calcium citrate after Roux-en-Y gastric bypass.
- Response to Taylor and Curhan.
- Critical appraisal of oral Calcium load test for indirect assessment of intestinal Calcium absorption.
- Lack of deleterious effect of slow-release sodium fluoride treatment on cortical bone histology and quality in osteoporotic patients.
- Uric acid nephrolithiasis: pathogenesis and treatment.
- Citraturic Response to oral citric acid load.
- Management of Renal osteodystrophy.
- Impaired bone formation in male idiopathic osteoporosis: further reduction in the presence of concomitant hypercalciuria.
- Contrasting effects of various potassium salts on Renal citrate excretion.
- Fluoride bioavailability from immediate-release sodium fluoride with Calcium carbonate compared with slow-release sodium fluoride with Calcium citrate.
- Assessment by reflection ultrasound method of the effect of intermittent slow-release sodium fluoride-Calcium citrate therapy on material strength of bone.
- Fluoride bioavailability from slow-release sodium fluoride given with Calcium citrate.
- Effect of intermittent therapy With a slow-release fluoride preparation.
- Lack of effect of 24,25-dihydroxyvitamin D3 administration on parameters of Calcium metabolism.
- Safe and effective treatment of osteoporosis With intermittent slow release sodium fluoride: augmentation of vertebral bone mass and inhibition of fractures.
- The spectrum of metabolic abnormalities in patients With cystine nephrolithiasis.
- Impaired adaptation to salt-induced urinary Calcium losses in postmenopausal osteoporosis.
- Alkali action on the urinary crystallization of Calcium salts: contrasting responses to sodium citrate and potassium citrate.
- Attainment of therapeutic fluoride levels in serum Without major side effects using a slow-release preparation of sodium fluoride in postmenopausal osteoporosis.
- Management of cystine nephrolithiasis With alpha-mercaptopropionylglycine.
- Nephrolithiasis from Calcium supplementation.
- Assessment of the pathogenetic role of physical exercise in Renal stone formation.
- Successful management of uric acid nephrolithiasis With potassium citrate.
- Hypercalciuria and altered intestinal calcium absorption occurring independently of vitamin D in incomplete distal renal tubular Acidosis.
- Short-term 1,25-dihydroxyvitamin D3 administration raises serum osteocalcin in patients With postmenopausal osteoporosis.
- Long-term treatment of Calcium nephrolithiasis with potassium citrate.
- Disturbances in mineral Metabolism after successful renal transplantation.
- Lack of effect of prostaglandin inhibition on Calcium excretion in normal volunteers.
- Postmenopausal osteoporosis as a manifestation of renal hypercalciuria With secondary hyperparathyroidism.
- Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular Acidosis.
- Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis.
- Exaggerated natriuretic and calciuric responses to hydrochlorothiazide in Renal hypercalciuria but not in absorptive hypercalciuria.
- Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria.
- Reduction in intestinal Calcium absorption by hydrochlorothiazide in postmenopausal osteoporosis.
Procedures Preformed
- Hemodialysis
Conditions Treated
- Acidosis
- Acute Glomerulonephritis
- Acute Kidney Failure
- Calcium Metabolism Disorders
- View All
Doctors Specialties
- Nephrology
- Internal Medicine
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Shiraz University of Medical Sciences
Hospital
-
University of Texas Southwestern Medical Center
Drug Facts
| NPI NUMBER | 1730148057 | |
| NPPES Provider LastName | SAKHAEE | |
| NPPES Provider FirstName | KHASHAYAR | |
| NPPES Provider ZIPCode | 753907201 | |
| NPPES Provider State | TX | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 514.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1730148057 |
| Last Name Of The Provider | SAKHAEE |
| First Name Of The Provider | KHASHAYAR |
| View All |
Similar Doctors
|
|
Dr. Albert D. Roberts, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathryn A. Trissell, MD |
|
|
Dr. Kimberly D. Johnson, DO |
|
|
Dr. Roma M. Mehta, MD |
|
Dr. Long Tran, MD |
|
|
Dr. Payaswini Vasanth, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth A. Kummer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bonnie J. Lammers, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anees J. Omar, MD
This Doctor is OpenDoctor Recommended.
|